PGIMER Chandigarh has made a significant advancement in chronic pain management by introducing the world's first Fluorine-18 Sodium Fluoride (18F-NaF) PET-CT guided steroid injection technique. This innovative approach allows for precise identification of pain-generating sites, leading to targeted treatment that significantly improves patient outcomes. According to Prof. Vivek Lal, the director of PGIMER, this method integrates advanced imaging with therapy, potentially revolutionizing pain management worldwide. The multidisciplinary team, including experts from Nuclear Medicine and Orthopaedics, reported that 84% of patients experienced substantial pain relief at three months post-treatment. The procedure is not only effective but also affordable, costing around ₹1,000 (approximately $12 USD) plus consumables, making it accessible to many. Clinical evidence supporting this technique has been published in the European Journal of Nuclear Medicine and Molecular Imaging, highlighting its efficacy and safety.